Company Overview
PYXIS ONCOLOGY, INC.
PYXSRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
14M
2025 FY
Net Income
-80M
2025 FY
Shares Outstanding
62M
2025 FY
EPS
-1.28USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1782223
Exchange
Nasdaq
Location
US